Clinical Trials in Phoenix

Showing 6601-6620 of 12,606 trials

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

NCT04006236

This is a randomized, controlled, double-blind, multicenter parallel study to evaluate the growth, tolerance and compliance of healthy infants fed infant formulas with extensively hydrolyzed casein protein.

Infant Development

Abbott Nutrition245 participantsStarted Aug 2019

Phoenix, Arizona, United States • Tucson, Arizona, United States • College Park, Georgia, United States +14 more locations

COMPLETEDPhase 2/3< 1 mile

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

NCT03514641

This integrated assessment consists of two studies, 603A and 603B, to be carried out sequentially in a common study population. Participating subjects informed of the trial design and their consent to participate in both studies were to be obtained in a single consent form. Approximately 680 male or female adult subjects were to be enrolled.

Essential Hypertension

Theracos673 participantsStarted Oct 2017

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +84 more locations

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Find Trials by Condition in Phoenix

Barrow Ruptured Aneurysm Trial

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Dose Range Study of CD5789 in Acne Vulgaris

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

Assessing Symptomatic Clinical Episodes in Depression

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

A Cohort Study of Operationally Tolerant Allograft Recipients

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)